Page 7 of 8
Organic & Biomolecular Chemistry
DOI: 10.1039/C4OB02567A
To a 5ꢀmL screwꢀcapped vial equipped with a magnetic stirring
bar were added 1ꢀ(azidomethyl)ꢀ2ꢀ(phenylethynyl)benzene 5f-5k 60 25.6, 44.4, 101.9, 102.2, 103.9, 120.3, 120.4, 126.9, 127.9, 128.9,
2H), 7.89 (d, J = 7.3 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ
(0.05 mmol), Pd(PPh3)4 (2.9 mg, 0.0025 mmol), K3PO4 (53.1 mg,
0.25 mmol), allyl methyl carbonate 2a (28.4 ꢁL, 0.25 mmol), and
DMF (1 mL). The mixture was stirred at 100 °C. The reaction
progress was monitored by TLC (hexane/ethyl acetate, 5/1). After
130.3, 130.4, 131.6, 136.4, 138.3, 144.5, 148.1, 148.3. IR (KBr)
3070, 2913, 2844, 1646, 1467, 1352, 1294, 1033, 698 cmꢀ1.
HRMSꢀEI (m/z) [M]+ Calcd for C20H16NO2 [M﹣H]+ 302.1181;
Found 302.1176.
5
consumption of the staring material 5f-5k, the reaction mixture 65 8-allyl-5-methyl-7-p-tolyl-[1,3]dioxolo[4,5-g]isoquinoline (7f).
1
was cooled to room temperature and filtered through a short
column with the use of ethyl acetate as eluent. After the solvent
10 was removed under reduced pressure, the residue was purified by
column chromatography (silica gel, hexane/ethyl acetate,
30/1~5/1) to provide the product 7a-7f.
Yellow oil (14.3 mg, 90%); H NMR (400 MHz, CDCl3) δ 1.83
(s, 3H), 2.43 (s, 3H), 2.85 (dd, J = 14.0, 6.6 Hz, 1H), 2.99 (dd, J =
14.0, 7.8 Hz, 1H), 5.06ꢀ4.84 (m, 2H), 5.45ꢀ5.28 (m, 1H), 6.06 (s,
2H), 6.88 (s, 1H), 7.36ꢀ7.27 (m, 3H), 7.78 (d, J = 7.9 Hz, 2H).
70 13C NMR (100 MHz, CDCl3) δ 21.3, 25.6, 44.4, 101.9, 102.1,
103.9, 120.2, 120.6, 126.8, 128.7, 129.6, 130.4, 130.4, 136.1,
137.8, 138.3, 144.4, 148.1, 148.1. IR (KBr) 3075, 2982, 2919,
1745, 1601, 1473, 1352, 1294, 1039, 923, 819, 692 cmꢀ1. HRMSꢀ
EI (m/z) [M]+ Calcd for C21H18NO2 [M﹣H]+ 316.1338; Found
4-allyl-1-methyl-3-phenylisoquinoline (7a). Yellow oil (11.0
1
mg, 85%); H NMR (400 MHz, CDCl3) δ 1.88 (s, 3H), 2.92 (dd,
15 J = 14.1, 6.6 Hz, 1H), 3.05 (dd, J = 14.1, 7.9 Hz, 1H), 5.03ꢀ4.87
(m, 2H), 5.39ꢀ5.28 (m, 1H), 7.49ꢀ7.36 (m, 4H), 7.53 (t, J = 7.7 Hz,
2H), 7.88 (t, J = 7.3 Hz, 1H), 7.97 (d, J = 7.9 Hz, 2H). 13C NMR 75 316.1341.
(100 MHz, CDCl3) δ 25.5, 44.4, 120.3, 121.2, 122.7, 126.9, 127.1,
128.1, 128.4, 128.7, 128.9, 128.9, 130.4, 131.5, 136.4, 139.5,
20 150.2. IR (KBr) 3070, 2982, 2925, 1641, 1444, 1352, 988, 918,
762, 692 cmꢀ1. HRMSꢀEI (m/z) [M]+ Calcd for C19H16N [M﹣H]+
258.1283; Found 258.1279.
8-allyl-7-(4-chlorophenyl)-5-phenyl-[1,3]dioxolo[4,5 g]isoquin
-oline (7g). Yellow oil (12.0 mg, 60%); 1H NMR (400 MHz,
CDCl3) δ 3.36 (dd, J = 14.1, 6.4 Hz, 1H), 3.55 (dd, J = 14.1, 7.6
Hz, 1H), 5.04ꢀ4.84 (m, 2H), 5.25ꢀ5.14 (m, 1H), 6.13ꢀ6.00 (m,
80 2H), 6.88 (s, 1H), 7.29ꢀ7.26 (m, 1H), 7.39ꢀ7.30 (m, 5H), 7.53ꢀ
7.46 (m, 2H), 7.86 (d, J = 8.5 Hz, 2H). 13C NMR (100 MHz,
CDCl3) δ 43.0, 102.0, 102.1, 105.3, 120.3, 120.9, 126.0, 128.2,
128.6, 129.0, 129.1, 129.2, 129.9, 130.0, 133.8, 137.1, 137.5,
139.0, 143.9, 148.3, 148.6. IR (KBr) 2905, 1470, 1345, 1029, 928,
4-allyl-1,3-diphenylisoquinoline (7b). Yellow oil (14.9 mg,
1
93%); H NMR (400 MHz, CDCl3) δ 3.44 (dd, J = 14.0, 6.4 Hz,
25 1H), 3.59 (dd, J = 14.0, 7.7 Hz, 1H), 5.02ꢀ4.82 (m, 2H), 5.23ꢀ5.12
(m, 1H), 7.49ꢀ7.30 (m, 9H), 7.54 (t, J = 7.5 Hz, 2H), 7.93 (d, J =
7.5 Hz, 1H), 8.01 (d, J = 7.7 Hz 2H). 13C NMR (100 MHz, 85 827, 732 cmꢀ1. HRMSꢀEI (m/z) [M]+ Calcd for C25H17NO2Cl [M
CDCl3) δ 43.2, 120.7, 121.3, 124.2, 126.0, 127.1, 128.2, 128.5,
128.5, 128.8, 128.8, 128.9, 129.0, 130.0, 131.4, 137.4, 139.1,
30 139.5, 139.5, 149.4. IR (KBr) 3058, 2912, 1646, 1491, 1444,
1352, 982, 756, 698 cmꢀ1. HRMSꢀEI (m/z) [M]+ Calcd for
C24H18N [M﹣H]+ 320.1439; Found 320.1441.
﹣H]+ 398.0943; Found 398.0943.
4-allyl-3-(4-fluorophenyl)-1-methylisoquinoline (7h). Yellow
1
oil (12.9 mg, 93%); H NMR (400 MHz, CDCl3) δ 1.88 (s, 3H),
2.92 (dd, J = 14.1, 6.6 Hz, 1H), 3.04 (dd, J = 14.1, 7.9 Hz, 1H),
90 5.04ꢀ4.88 (m, 2H), 5.39ꢀ5.28 (m, 1H), 7.28ꢀ7.17 (m, 2H), 7.49ꢀ
7.40 (m, 3H), 7.83 (t, J = 6.4 Hz, 1H), 7.97ꢀ7.89 (m, 2H). 13C
NMR (100 MHz, CDCl3) δ 25.5, 44.3, 120.4, 121.0, 122.7, 122.8,
126.7, 127.7, 127.7, 128.5, 128.7, 128.8, 130.3, 130.3, 136.2,
138.6, 150.1. IR (KBr) 2911, 2845, 1506, 1220, 833, 756, 577
4-allyl-7-chloro-1,3-diphenylisoquinoline (7c). Yellow oil
(15.5 mg, 87%); 1H NMR (400 MHz, CDCl3) δ 3.42 (dd, J = 14.1,
35 6.4 Hz, 1H), 3.58 (dd, J = 14.1, 7.7 Hz, 1H), 5.06ꢀ4.84 (m, 2H),
5.23ꢀ5.13 (m, 1H), 7.47ꢀ7.30 (m, 8H), 7.58ꢀ7.50 (m, 2H), 7.84 (d,
J = 8.2 Hz, 1H), 7.96 (t, J = 7.8 Hz 2H). 13C NMR (100 MHz, 95 cmꢀ1. HRMSꢀEI (m/z) [M]+ Calcd for C19H15NF [M ﹣ H]+
CDCl3) δ 43.0, 121.2, 122.2, 124.6, 125.6, 125.9, 125.9, 127.0,
128.4, 128.8, 128.8, 129.0, 129.1, 129.5, 131.1, 134.6, 136.6,
40 138.5, 139.6, 151.2. IR (KBr) 3064, 2919, 1635, 1496, 1450,
1352, 982, 768, 698 cmꢀ1. HRMSꢀEI (m/z) [M]+ Calcd for
C24H17NCl [M﹣H]+ 354.1050; Found 354.1053.
276.1189; Found 276.1190.
4-allyl-1-phenyl-3-m-tolylisoquinoline (7i). Yellow oil (14.9 mg,
1
89%); H NMR (400 MHz, CDCl3) δ 2.42 (s, 3H), 3.37 (dd, J =
14.0, 6.2 Hz, 1H), 3.52 (dd, J = 14.0, 7.7 Hz, 1H), 4.98ꢀ4.74 (m,
100 2H), 5.16ꢀ5.05 (m, 1H), 7.22ꢀ7.14 (m, 1H), 7.44ꢀ7.22 (m, 9H),
7.72 (d, J = 7.6 Hz, 1H), 7.80 (s, 1H), 7.86 (d, J = 5.5 Hz, 1H).
13C NMR (100 MHz, CDCl3) δ 21.5, 43.1, 120.7, 121.3, 124.1,
124.2, 126.0, 127.1, 127.8, 127.9, 128.5, 128.8, 129.0, 130.0,
131.3, 137.4, 137.5, 138.6, 138.7, 139.2, 139.2, 139.6, 149.4. IR
4-allyl-3-cyclohexyl-1-phenylisoquinoline (7d). Yellow oil
1
(12.9 mg, 79%); H NMR (400 MHz, CDCl3) δ 1.54ꢀ1.30 (m,
45 3H), 1.84ꢀ1.69 (m, 3H), 1.91 (d, J = 12.9 Hz, 2H), 2.15ꢀ2.05 (m,
2H), 3.05 (t, J = 12.0 Hz, 1H), 3.36 (dd, J = 14.0, 6.3 Hz, 1H),
3.49 (dd, J = 14.0, 7.7 Hz, 1H), 4.97ꢀ4.76 (m, 2H), 5.18ꢀ5.06 (m, 105 (KBr) 2911, 2851, 1589, 1446, 1220, 916, 658 cmꢀ1. HRMSꢀEI
1H), 7.36ꢀ7.28 (m, 6H), 7.46ꢀ7.38 (m, 2H), 7.67 (d, J = 7.6 Hz,
1H), 13C NMR (100 MHz, CDCl3) δ 26.1, 26.5, 32.6, 36.3, 43.3,
50 120.4, 121.5, 124.1, 126.0, 127.5, 127.7, 128.3, 128.3, 128.6,
128.9, 130.1, 137.0, 139.4, 144.3, 148.9. IR (KBr) 3064, 2931,
2856, 1641, 1444, 1334, 988, 750, 692 cmꢀ1. HRMSꢀEI (m/z)
[M]+ Calcd for C24H24N [M﹣H]+ 326.1909; Found 326.1911.
8-allyl-5-methyl-7-phenyl-[1,3]dioxolo[4,5-g]isoquinoline (7e).
(m/z) [M]+ Calcd for C25H20N [M ﹣ H]+ 334.1596; Found
334.1592.
General Procedure for the ring closing reaction (12)
110 To a 5ꢀmL screwꢀcapped vial equipped with a magnetic stirring
bar were added 3,4ꢀdiallylquinolines 3a (14.3 mg, 0.05 mmol),
Grubbs I catalyst (4.1 mg, 0.005 mmol), and CH2Cl2 (1 mL). The
mixture was stirred for 1 h at 40 °C. The reaction progress was
monitored by TLC (hexane/ethyl acetate, 10/1). After
115 consumption of the staring material 3a, the reaction mixture was
1
55 Yellow oil (12.3 mg, 81%); H NMR (400 MHz, CDCl3) δ 1.83
(s, 3H), 2.85 (dd, J = 14.0, 6.6 Hz, 1H), 3.00 (dd, J = 14.0, 7.8 Hz,
1H), 5.06ꢀ4.87 (m, 2H), 5.43ꢀ5.28 (m, 1H), 6.07 (s, 2H), 6.88 (s,
1H), 7.31 (s, 1H), 7.38 (t, J = 7.1 Hz, 1H), 7.51 (t, J = 7.7 Hz,
This journal is © The Royal Society of Chemistry [year]
Journal Name, [year], [vol], 00–00 | 7